ANXA1 and fatty liver disease: Here we clearly demonstrate a positive correlation between increased hepatic steatosis (fatty liver index), waist circumference (Table 1) and elevated plasma ANXA1 levels (Figure 1A); suggesting that high ANXA1 levels may also be a biomarker of the development of fatty liver disease (although this hypothesis warrants further investigation).